Founded in 1952 by Nobel Laureate E.O. Lawrence, the Lawrence Livermore National Laboratory is managed by the Department of Energy. With a large multi-disciplinary bioinformatics team, they focus on developing and delivering advanced detection assays.
Dr Crystal Jaing, Group Leader, Applied Genomics, Physical Life Sciences Directorate, Lawrence Livermore National Laboratory, joined us at the World Vaccine Congress in Washington in 2012 to discuss their creation of microarrays to characterise known, emerging and engineered pathogens, focusing on: Virulence & Genetic Engineering array, Lawrence Livermore Microbial detection array and also the Whole genome SNP arrays. These arrays can be applied in vaccine safety and to therefore ensure the safety of biologicals. Tell us your views on vaccine safety below!
Why not download the full presentation and discover more about exploring the potential of a microbial detection array:
- Highlighting the comprehensive and cost effective nature of this technology alongside its sensitivity and speed to understand the underlying principals
- Can this detection system be utilised across the vaccine industry – including novel cell lines?
- Exploring these possibilities through case studies